Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference

The new mini-textbook by Kamps & Hoffmann
PDF, 110 pages


  Prostate Cancer

  Free Subscription


10.02.2020

1 Acta Radiol
2 Anticancer Res
2 BMC Cancer
1 Br J Radiol
6 Cancer
1 Cancer Res
1 Eur Radiol
1 Eur Urol
7 Int J Radiat Oncol Biol Phys
1 J Cell Physiol
1 J Magn Reson Imaging
1 J Urol
4 Nat Rev Urol
1 Oncol Rep
1 PLoS Med
2 PLoS One
8 Prostate


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Radiol

  1. JIANG Y, Li C, Liu Y, Shi K, et al
    Histogram analysis in prostate cancer: a comparison of diffusion kurtosis imaging model versus monoexponential model.
    Acta Radiol. 2020 Feb 2:284185120901504. doi: 10.1177/0284185120901504.
    PubMed     Text format    


    Anticancer Res

  2. XOXAKOS I, Petraki C, Msauel P, Armakolas A, et al
    Expression of Kisspeptin (KISS1) and its Receptor GPR54 (KISS1R) in Prostate Cancer.
    Anticancer Res. 2020;40:709-718.
    PubMed     Text format     Abstract available

  3. MIYAKE H, Watanabe K, Matsushita Y, Watanabe H, et al
    Assessment of Factors Predicting Disease Progression in Japanese Patients With Non-Metastatic Castration-resistant Prostate Cancer.
    Anticancer Res. 2020;40:1101-1106.
    PubMed     Text format     Abstract available


    BMC Cancer

  4. BUWENGE M, Scirocco E, Deodato F, Macchia G, et al
    Radiotherapy of prostate cancer: impact of treatment characteristics on the incidence of second tumors.
    BMC Cancer. 2020;20:90.
    PubMed     Text format     Abstract available

  5. ZHOU X, Ning Q, Jin K, Zhang T, et al
    Development and validation of a preoperative nomogram for predicting survival of patients with locally advanced prostate cancer after radical prostatectomy.
    BMC Cancer. 2020;20:97.
    PubMed     Text format     Abstract available


    Br J Radiol

  6. ADRIAN G, Konradsson E, Lempart M, Back S, et al
    The FLASH effect depends on oxygen concentration.
    Br J Radiol. 2020;93:20190702.
    PubMed     Text format     Abstract available


    Cancer

  7. ZHAI Z, Zheng Y, Li N, Deng Y, et al
    Incidence and disease burden of prostate cancer from 1990 to 2017: Results from the Global Burden of Disease Study 2017.
    Cancer. 2020 Feb 3. doi: 10.1002/cncr.32733.
    PubMed     Text format     Abstract available

  8. LEHRER SP
    Obesity and aggressive prostate cancer.
    Cancer. 2020 Feb 5. doi: 10.1002/cncr.32761.
    PubMed     Text format    

  9. JOSHI SS, Filson CP
    Reply to Obesity and aggressive prostate cancer and the golden rule: Do not do to others what you do not want done to yourself.
    Cancer. 2020 Feb 5. doi: 10.1002/cncr.32759.
    PubMed     Text format    

  10. BUTLER SS, Mahal BA
    Reply to Obesity and aggressive prostate cancer and the golden rule: Do not do to others what you do not want done to yourself.
    Cancer. 2020 Feb 5. doi: 10.1002/cncr.32758.
    PubMed     Text format    

  11. SU ZT, Patel HD, Epstein JI, Pavlovich CP, et al
    Downgrading of grade group 2 intermediate-risk prostate cancer from biopsy to radical prostatectomy: Comparison of outcomes and predictors to identify potential candidates for active surveillance.
    Cancer. 2020 Feb 7. doi: 10.1002/cncr.32709.
    PubMed     Text format     Abstract available

  12. LYNCH SM, Sorice K, Tagai EK, Handorf EA, et al
    Use of empiric methods to inform prostate cancer health disparities: Comparison of neighborhood-wide association study "hits" in black and white men.
    Cancer. 2020 Feb 3. doi: 10.1002/cncr.32734.
    PubMed     Text format     Abstract available


    Cancer Res

  13. CERASUOLO M, Maccarinelli F, Coltrini D, Mahmoud AM, et al
    Modeling acquired resistance to the second-generation androgen receptor antagonist enzalutamide in the TRAMP model of prostate cancer.
    Cancer Res. 2020 Feb 6. pii: 0008-5472.CAN-18-3637.
    PubMed     Text format     Abstract available


    Eur Radiol

  14. QUENTIN M, Arsov C, Ullrich T, Valentin B, et al
    Comparison of analgesic techniques in MRI-guided in-bore prostate biopsy.
    Eur Radiol. 2019;29:6965-6970.
    PubMed     Text format     Abstract available


    Eur Urol

  15. RUBIO-BRIONES J
    Re:Cabazitaxel Versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer.
    Eur Urol. 2020 Feb 3. pii: S0302-2838(20)30054.
    PubMed     Text format    


    Int J Radiat Oncol Biol Phys

  16. LARGENT A, Barateau A, Nunes JC, Mylona E, et al
    Comparison of Deep Learning-Based and Patch-Based Methods for Pseudo-CT Generation in MRI-Based Prostate Dose Planning.
    Int J Radiat Oncol Biol Phys. 2019;105:1137-1150.
    PubMed     Text format     Abstract available

  17. MARPLES B, Wilson GD
    Predicting Outcome using Genomic-Based Liquid Biomarkers.
    Int J Radiat Oncol Biol Phys. 2020;106:1-4.
    PubMed     Text format    

  18. KANG J, Thompson RF, Fuller CD, Camphausen KA, et al
    In Regard to Wallner et al.
    Int J Radiat Oncol Biol Phys. 2020;106:217-218.
    PubMed     Text format    

  19. BALLAS LK
    Nodal Recurrence From Prostate Adenocarcinoma: Curable.
    Int J Radiat Oncol Biol Phys. 2020;106:238-239.
    PubMed     Text format    

  20. VAN SON MJ, Peters M, Moerland MA, Lagendijk JJW, et al
    MRI-guided ultrafocal salvage high-dose-rate brachytherapy for localized radiorecurrent prostate cancer: updated results of 50 patients.
    Int J Radiat Oncol Biol Phys. 2020 Jan 29. pii: S0360-3016(20)30129.
    PubMed     Text format     Abstract available

  21. KOONTZ BF, Pra AD
    Shifting the Curtain-Can We Make Sense of the Whole Pelvis Controversy?
    Int J Radiat Oncol Biol Phys. 2020;106:534-536.
    PubMed     Text format    

  22. LIN J, Den RB, Greenspan J, Showalter TN, et al
    Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Feb 3. pii: S0360-3016(19)34522.
    PubMed     Text format     Abstract available


    J Cell Physiol

  23. CHEN Y, Wang K, Liu T, Chen J, et al
    Decreased glucose bioavailability and elevated aspartate metabolism in prostate cancer cells undergoing epithelial-mesenchymal transition.
    J Cell Physiol. 2020 Feb 4. doi: 10.1002/jcp.29490.
    PubMed     Text format     Abstract available


    J Magn Reson Imaging

  24. CUI Y, Han S, Liu M, Wu PY, et al
    Diagnosis and Grading of Prostate Cancer by Relaxation Maps From Synthetic MRI.
    J Magn Reson Imaging. 2020 Feb 6. doi: 10.1002/jmri.27075.
    PubMed     Text format     Abstract available


    J Urol

  25. ALDER R, Zetner D, Rosenberg J
    Incidence of Inguinal Hernia after Radical Prostatectomy: A Systematic Review and Meta-Analysis.
    J Urol. 2020;203:265-274.
    PubMed     Text format     Abstract available


    Nat Rev Urol

  26. MARTINEZ-BOSCH N, Rodriguez-Vida A, Juanpere N, Lloreta J, et al
    Galectins in prostate and bladder cancer: tumorigenic roles and clinical opportunities.
    Nat Rev Urol. 2019 Apr 23. pii: 10.1038/s41585-019-0183.
    PubMed     Text format     Abstract available

  27. HIGANO C
    Enzalutamide, apalutamide, or darolutamide: are apples or bananas best for patients?
    Nat Rev Urol. 2019;16:335-336.
    PubMed     Text format    

  28. DINGES SS, Hohm A, Vandergrift LA, Nowak J, et al
    Cancer metabolomic markers in urine: evidence, techniques and recommendations.
    Nat Rev Urol. 2019;16:339-362.
    PubMed     Text format     Abstract available

  29. FLIPPOT R, Beinse G, Boileve A, Vibert J, et al
    Long non-coding RNAs in genitourinary malignancies: a whole new world.
    Nat Rev Urol. 2019;16:484-504.
    PubMed     Text format     Abstract available


    Oncol Rep

  30. KASAJIMA R, Yamaguchi R, Shimizu E, Tamada Y, et al
    Variant analysis of prostate cancer in Japanese patients and a new attempt to predict related biological pathways.
    Oncol Rep. 2020 Jan 27. doi: 10.3892/or.2020.7481.
    PubMed     Text format     Abstract available


    PLoS Med

  31. FREDSOE J, Koetsenruyter J, Vedsted P, Kirkegaard P, et al
    The effect of assessing genetic risk of prostate cancer on the use of PSA tests in primary care: A cluster randomized controlled trial.
    PLoS Med. 2020;17:e1003033.
    PubMed     Text format     Abstract available


    PLoS One

  32. DURST MA, Ratia K, Lavie A
    Identifying small molecule probes of ENTPD5 through high throughput screening.
    PLoS One. 2019;14:e0210305.
    PubMed     Text format     Abstract available

  33. LUO Z, Farnham PJ
    Genome-wide analysis of HOXC4 and HOXC6 regulated genes and binding sites in prostate cancer cells.
    PLoS One. 2020;15:e0228590.
    PubMed     Text format     Abstract available


    Prostate

  34. NICKKHOLGH B, Sittadjody S, Ordonez K, Rothberg MB, et al
    Protein kinase D1 induces G1-phase cell-cycle arrest independent of Checkpoint kinases by phosphorylating Cell Division Cycle Phosphatase 25.
    Prostate. 2019;79:1053-1058.
    PubMed     Text format     Abstract available

  35. ZHANG P, Lu Y, Kong Z, Zhang Y, et al
    Androgen-responsive lncRNA LINC00304 promotes cell cycle and proliferation via regulating CCNA1.
    Prostate. 2019;79:994-1006.
    PubMed     Text format     Abstract available

  36. HUANG SY, Huang GJ, Hsieh PF, Wu HC, et al
    Osajin displays potential antiprostate cancer efficacy via impairment of fatty acid synthase and androgen receptor expression.
    Prostate. 2019;79:1543-1552.
    PubMed     Text format     Abstract available

  37. AMEND SR, Torga G, Lin KC, Kostecka LG, et al
    Polyploid giant cancer cells: Unrecognized actuators of tumorigenesis, metastasis, and resistance.
    Prostate. 2019;79:1489-1497.
    PubMed     Text format     Abstract available

  38. YEON A, Wang Y, Su S, Lo EM, et al
    Syngeneic murine model for prostate cancer using RM1 cells transfected with gp100.
    Prostate. 2020 Feb 3. doi: 10.1002/pros.23957.
    PubMed     Text format     Abstract available

  39. YAMADA Y, Sakamoto S, Rii J, Yamamoto S, et al
    How many bone metastases may be defined as high-volume metastatic prostate cancer in Asians: A retrospective multicenter cohort study.
    Prostate. 2020 Feb 3. doi: 10.1002/pros.23958.
    PubMed     Text format     Abstract available

  40. GREENBERG S, Slager S, Neil BO, Cooney K, et al
    What men want: Qualitative analysis of what men with prostate cancer (PCa) want to learn regarding genetic referral, counseling, and testing.
    Prostate. 2020 Feb 6. doi: 10.1002/pros.23959.
    PubMed     Text format     Abstract available

  41. AARON-BROOKS LM, Sasaki T, Vickman RE, Wei L, et al
    Hyperglycemia and T Cell infiltration are associated with stromal and epithelial prostatic hyperplasia in the nonobese diabetic mouse.
    Prostate. 2019;79:980-993.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: